Healing of leg ulcers with hydroxyurea in thalassaemia intermedia patients with associated endocrine complications

Pediatric Endocrinology Reviews

Volumn 2, Issue SUPPL. 2, 2004, Pages 319-322

  Gamberini, Maria R ^a   Fortini, Monica ^a   De Sanctis, Vincenzo ^a  

^a S ANNA HOSPITAL   (Italy)

Author keywords

Hydroxyurea; Leg ulcers; Thalassaemia intermedia

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN F; HYDROXYUREA;

ADULT; BETA THALASSEMIA; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE ASSOCIATION; ENDOCRINE DISEASE; FEMALE; FEVER; HUMAN; LEG ULCER; MALE; RECURRENT DISEASE; SIDE EFFECT; STATISTICAL SIGNIFICANCE; STOMACH PAIN; ULCER HEALING;

ADULT; BETA-THALASSEMIA; FEMALE; HUMANS; HYDROXYUREA; LEG ULCER; MALE;

EID: 12544253343     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Cacace E, Manconi E, Binaghi F, Perpigano G, Pitzus G, Carcassi U. Leg ulcers in β-thalassemia intermedia. In: Thalassaemia Today, The Mediterranean Experience. Published by: Centro Trasfusionale Ospedale Maggiore Policlinico di Milano Editore, Milano, Italy, 1987;559-574
2. Gimmon Z, Wexler MR, Rachmilewitz EA. Pathogenesis of juvenile leg ulcers in beta-thalassaemia major and intermedia. Plast Reconstruct Surg 1982;69:320-323
3. Hovav T, Goldard A, Artmann G, Yedgar S, Barshtein G. Enhanced adherence of beta-thalassaemic erythrocytes to endothelial cells. Br J Haematol 1999;106:178-181
4. Wethers DL, Ramirez GM, Koshy M, Steinberg MH, Phillips G Jr, Siegel RS, Eckman JR, Prchal JT and the RGD Study Group. Accelerated healing of chronic sickle-cell leg ulcers treated with RGD peptide matrix. Blood 1994;84:1775-1779
5. Eckman JR. Leg ulcers in sickle-cell disease. Hematol Oncol Clin North Am. 1996;10:1333-1344
6. Josifova D, Gatt G, Aquilina A, Serafimov V, Vella A, Felice AE. Treatment of leg ulcers with platelet-derived wound healing factor (PDWHFs) in a patient with beta thalassemia intermedia. Br J Haematol 2001;112:527-529
7. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med. 1995;332:1317-1322
8. Hajjar FM, Pearson HA. Pharmacologic treatment of thalassaemia intermedia with hydroxyurea. J Pediatr 1994;125:490-492
9. Zeng YT, Huang SZ, Ren Zr, Lu ZH, Zeng FY, Schechter AN, Rodgers GP. Hydroxyurea therapy in β-thalassaemia intermedia: improvement in haematological parameters due to enhanced β-globin synthesis. Br J Haematol 1995;90:557-563
10. Arruda VR, Lima CS, Saad ST, Costa FF. Successful use of hydroxyurea in β-thalassaemia major. N Engl J Med 1997;336:964
11. Olivieri NF, Rees DC, Ginder GD, Thein SL, Brittenham Gm, Waye JS, Weatherall DJ. Treatment of thalassaemia major with phenylbutyrate and hydroxyurea. Lancet 1997;350:491-492
12. Konstantopoulos K, Vagiopoulos G, Kantouni R, Lymperi S, Patriarcheas G, Georgakopoulos D, Fessas P. A case of spinal cord compression by extramedullary haemopoiesis in a thalassaemic patient: a putative role for hydroxyurea? Haematologica 1992;77:352-354
13. Saxon B R, Rees D, Olivieri NF. Regression of extramedullary haemopoiesis and augmentation of foetal haemoglobin concentration during hydroxyurea therapy in beta thalassaemia. Br J Haematol 1998;101:416-419
14. Di Palma A, Olivieri NF, Sprocati M, Tenan R, Vullo C. Rapid healing of chronic leg ulcers in patients with thalassaemia during treatment with hydroxyurea. In: New trends in therapy for hemoglobinopathies and thalassaemia, Paris, September 19-22, 1994, Poster VIII,20
15. Sher GD, Olivieri NF. Rapid healing of chronic leg ulcers during butyrate therapy in patients with sickle cell disease and thalassaemia. Blood 1997;84:2378-2379
16. Al-Momen A-K M. Recombinant human erythropoietin induced rapid healing of a chronic leg ulcer in a patient with sickle cell disease. Acta Haematol 1991;86:46-48
17. Ballas SK, Dover GJ, Charache S. Effect of hydroxyurea on the rheologic properties of sickle erythrocytes in vivo. Am J Hematol 1989;32:104-111
18. Orringer EP, Blythe DS, Johnson AE, Phillips G Jr, Dover GJ, Parker JC. Effects of hydroxyurea on hemoglobin F and water content in the red blood cells of dogs and of patients with sickle cell anemia. Blood 1991;78:212-216
19. Dormandy JA. Pathophysiology of venous leg ulceration - an update. Angiology 1997;48:71-75
20. Adragna NC, Fonseca P, Lauf PK. Hydroxyurea affects cell morphology, cation transport, and red blood cell adhesion in cultured vascular endothelial cells. Blood 1994;83:553-560
21. Saleh AW, Duits AJ, Gerbers A, de Vries C, Hillen HF. Cytokines and soluble adhesion molecules in sickle cell anaemia patients during hydroxyurea therapy. Acta Haematol 1998;100:26-31
22. Sirieix ME, Debure C, Baudot N, Dubertret L, Roux ME, Morel P, Frances C, Loubeyres S, Beylot C, Lambert D, Humbert P, Gauthier O, Dandurand M, Guillot B, Vaillant L, Lorette G, Bonnetblanc JM, Lok C, Denoeux JP. Leg ulcers and hydroxyurea: forty-one cases. Arch Dermatol 1999;135:818-820
23. Chaine B, Neonato MG, Girot R, Aractingi S. Cutaneous adverse reactions to hydroxyurea in patients with sickle cell disease. Arch Dermatol 2001;137:467-470